Core Viewpoint - The article highlights the upward trend in the industry, with the computing power industry chain and innovative pharmaceuticals becoming the main focus of recent structural market movements. Computing Power Industry Chain - The computing power industry chain saw significant gains, with sectors like optical modules and PCBs experiencing substantial increases. Notable stocks such as Xinyi Technology surged, reaching a historical high with a trading volume of nearly 20 billion yuan. Other stocks like Shenghong Technology and Dongshan Precision also hit record highs [1][3]. Innovative Pharmaceuticals - The innovative pharmaceutical sector experienced a strong rally, with stocks in chemical pharmaceuticals, traditional Chinese medicine, and CROs rising. Companies like Chengdu Xian Dao and Weikang Pharmaceutical reached their daily limit up, while stocks like BeiGene and Hengrui Medicine also saw increases [6][8]. - The innovative drug sector has been bolstered by three main factors: 1. Continuous policy support, including measures from the National Healthcare Security Administration aimed at enhancing the development of innovative drugs [9]. 2. Strong performance from leading pharmaceutical companies, with WuXi AppTec forecasting a revenue increase of approximately 20.64% for the first half of 2025 [9][10]. 3. Accelerated international breakthroughs, with China's share in global innovative drug BD transactions increasing significantly from 3% in 2019 to an expected 13% in 2024 [10]. Flying Car Sector - The flying car sector rebounded, with companies like Antai Technology and Alter seeing stock price increases. A significant procurement agreement worth $1 billion was signed for 350 eVTOL aircraft, setting a new record for single order amounts in China's eVTOL market [11][12][14]. - Additionally, XPeng Heavens announced a $250 million Series B financing round aimed at advancing the development and commercialization of flying cars [15].